Bibliography
- HOWARTH PH: Mediators of nasal blockage in allergic rhinitis. Allergy (1997) 52(40 Suppl.):12–18.
- COLEMAN RA, SMITH WL, NARUMIYAS: International Union of Pharmacology classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes Pharmacy]. Rev (1994) 46:205–229.
- JOHNSTON SL, SMITH S, HARRISON J, RITTER W, HOWARTH PH: The effect of BAY u 3405, a thromboxane receptor antagonist, on prostaglandin D2-induced nasal blockage. I Allergy Clirr. Immurrol (1993) 91(4):903–909.
- •Shows the lack of efficacy of a potent TP antagonist in this context.
- MCKENNIFF MG, NORMAN P, CUTHBERT NJ, GARDINER PJ: BAY u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro. Br j Pharmacol. (1991) 104(3):585–590.
- WRIGHT DH, FORD-HUTCHINSON AW, CHADEE K, METTERS KM: The human prostanoid DP receptor stimulates mucin secretion in L5174T cells. Br Pharmacol. (2000) 131 (8) :1537–1545.
- ••Highlights the potential utility of DP receptor antagonists to block mucus secretion.
- FORD-HUTCHINSON AW, GIRARD Y, LORD A et al.: The pharmacology of L-670,596, a potent and selective thromboxane/prostaglandin endoperoxide receptor antagonist. Can. I Physic] Pharmacol (1989) 67(9):989–993.
- ABRAMOVITZ, ADAM M, BOIE Y et al: The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim. Biophys. Acta (2000) 1483(2):285–293.
- ARIMURA A, YASUI K, KISHINO J et al.: Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, 5–5751.j Pharmacol Exp. Ther: (2001) 298(2):411–419.
- GERVAIS FG, CRUZ RP, CHATEAUNEUF A et al.: Selective modulation of chemokinesis, degranulation and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DPI Allergy konurrol. (2001) 108(6):982–988.